Adam C. Olson, MD, MSc-GH, discussed the infrastructure, training, and shared decision-making behind building a prostate HDR brachytherapy program.
|Articles|July 1, 1995
Oncology NEWS International
- Oncology NEWS International Vol 4 No 7
- Volume 4
- Issue 7
Toll- Free Mammography Information
ROCKVILLE, Md--The Food and Drug Administration has announced that the National Cancer Information Center toll-free hotline, 1-800-4-CANCER, will now provide the names of all US radiology centers that are equipped to perform high-quality mammography.
Advertisement
ROCKVILLE, Md--The Food and Drug Administration has announcedthat the National Cancer Information Center toll-free hotline,1-800-4-CANCER, will now provide the names of all US radiologycenters that are equipped to perform high-quality mammography.
Articles in this issue
over 31 years ago
House Panel Holds Hearing on Self-Referralover 31 years ago
Health-Related Legislationover 31 years ago
Mitoguazone Appears Promising in HIV-Associated Refractory NHLover 31 years ago
Responses to Anti-HER2 MoAb Seenover 31 years ago
MoAb May Improve Detection of Colon And Rectal Cancerover 31 years ago
Zeneca Files NDA for ArimidexAdvertisement
Related to this article
In HypoMast-IMNI, 16-fraction PMRT with internal mammary node irradiation matched conventional RT for locoregional control with less grade 3 skin toxicity.
In the phase 2 DALY 2-EU trial, zamto-cel prolonged median event-free survival vs R-GemOx in transplant-ineligible relapsed/refractory large B-cell lymphoma.
In a phase 2 trial, CD38-targeted immune-PET detected active multiple myeloma in some patients with no signs of disease on standard fluorodeoxyglucose PET/CT.
Tyler J. Wilhite, MD, discussed coordinating with rheumatology, orthopedic surgery, and primary care when treating patients with osteoarthritis with low-dose radiation therapy.
Rutika Mehta, MD, MPH, discussed biomarker testing, PD-L1–low treatment, FLOT dosing, early referral, and ctDNA in gastroesophageal cancer.
Tyler J. Wilhite, MD, discussed scaling low-dose radiation therapy for osteoarthritis from 1 patient to nearly 20 centers and the referral work behind it.
Joshua Richter, MD, and Marco Davila, MD, PhD, discuss early evaluation, sequencing, referral partnerships, and access to CAR T-cell therapy in myeloma.
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Measured Tumor Volume on PSMA PET-CT Linked With Survival in Prostate Cancer
2
Mapping Practical Steps to Expand CAR T-Cell Access in Multiple Myeloma
3
Scaling Low-Dose Radiation Therapy for Osteoarthritis Across a Network
4
Surgery Correlates With Better Survival Vs SABR in Early-Stage NSCLC
5